Ruikang Pharmaceutical Co., Ltd.

Legal Opinion on the Lawyer's Witness for the 2025 Annual Shareholders' Meeting

Announcement of the Resolutions of the 2025 Annual Shareholders' Meeting

Performance Report of Independent Director (Sun Kaoxiang)

Performance Report of Independent Director (Wang Jifa)

Performance Report of Independent Director (Liu Xijun) (1)

Compensation Management System for Directors and Senior Management of Ruikang Pharmaceutical Group Co., Ltd. (1)

Notice of the 2025 Annual Shareholders' Meeting

Announcement of the Resolution of the 22nd Meeting of the Fifth Board of Directors

Q1 2026 Report

Announcement on the 2025 Online Performance Presentation

Internal Control Audit Report

2025 Internal Control Self-Assessment Report

Announcement of Resolutions from the 21st Meeting of the 5th Board of Directors

Announcement on the 2025 Annual Profit Distribution Plan

Special Audit Report on Revenue Deduction Matters

Company's Evaluation Report on the Performance of the Accounting Firm in 2025

Report of the Board of Directors Audit Committee on the Performance of the Accounting Firm in 2025

Special Explanation on Non-Operating Fund Occupation and Other Related Party Fund Transactions

Summary Table of Non-Recurring Fund Occupation and Other Related Fund Transactions for Listed Companies in 2025

Special Opinion of the Board of Directors on the Independence of Independent Directors

2025 Annual Audit Report

2025 Annual Report

Summary of the 2025 Annual Report

Announcement on the Wholly-Owned Subsidiary Providing Guarantee for the Listed Company

Announcement on the partial release of pledge of shares by the actual controller